| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Retracted
Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome.
|
Science
|
2009
|
10.76
|
|
2
|
Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells.
|
Nat Med
|
2008
|
2.07
|
|
3
|
Role of cholesterol in human immunodeficiency virus type 1 envelope protein-mediated fusion with host cells.
|
J Virol
|
2002
|
1.64
|
|
4
|
Failure to confirm XMRV/MLVs in the blood of patients with chronic fatigue syndrome: a multi-laboratory study.
|
Science
|
2011
|
1.56
|
|
5
|
Heparan sulfate proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4+ T cells.
|
J Virol
|
2005
|
1.53
|
|
6
|
HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF165.
|
Blood
|
2009
|
1.27
|
|
7
|
Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome.
|
Virulence
|
2010
|
1.25
|
|
8
|
Ceramide, a target for antiretroviral therapy.
|
Proc Natl Acad Sci U S A
|
2004
|
1.22
|
|
9
|
A multicenter blinded analysis indicates no association between chronic fatigue syndrome/myalgic encephalomyelitis and either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus.
|
MBio
|
2012
|
1.11
|
|
10
|
Partial retraction. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome.
|
Science
|
2011
|
1.10
|
|
11
|
Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells.
|
J Virol
|
2006
|
1.09
|
|
12
|
Multiple sources of contamination in samples from patients reported to have XMRV infection.
|
PLoS One
|
2012
|
1.08
|
|
13
|
GLUT1 is not the primary binding receptor but is associated with cell-to-cell transmission of human T-cell leukemia virus type 1.
|
J Virol
|
2006
|
1.07
|
|
14
|
Levels of phospho-Smad2/3 are sensors of the interplay between effects of TGF-beta and retinoic acid on monocytic and granulocytic differentiation of HL-60 cells.
|
Blood
|
2002
|
1.02
|
|
15
|
Regulation of the cell-surface expression of an HTLV-I binding protein in human T cells during immune activation.
|
Blood
|
2002
|
0.98
|
|
16
|
Similar regulation of cell surface human T-cell leukemia virus type 1 (HTLV-1) surface binding proteins in cells highly and poorly transduced by HTLV-1-pseudotyped virions.
|
J Virol
|
2002
|
0.96
|
|
17
|
An inhibitor of glycosphingolipid metabolism blocks HIV-1 infection of primary T-cells.
|
AIDS
|
2004
|
0.93
|
|
18
|
Distribution of xenotropic murine leukemia virus-related virus (XMRV) infection in chronic fatigue syndrome and prostate cancer.
|
AIDS Rev
|
2010
|
0.93
|
|
19
|
K-Ras4B proteins are expressed in the nucleolus: Interaction with nucleolin.
|
Biochem Biophys Res Commun
|
2006
|
0.93
|
|
20
|
Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
|
Stem Cells
|
2003
|
0.92
|
|
21
|
Induction of human T cell leukemia virus type I receptors on quiescent naive T lymphocytes by TGF-beta.
|
J Immunol
|
2005
|
0.88
|
|
22
|
Preexisting infection with human T-cell lymphotropic virus type 2 neither exacerbates nor attenuates simian immunodeficiency virus SIVmac251 infection in macaques.
|
J Virol
|
2010
|
0.87
|
|
23
|
Levels of Smad7 regulate Smad and mitogen activated kinases (MAPKs) signaling and controls erythroid and megakaryocytic differentiation of erythroleukemia cells.
|
Platelets
|
2007
|
0.82
|
|
24
|
The receptor complex associated with human T-cell lymphotropic virus type 3 (HTLV-3) Env-mediated binding and entry is distinct from, but overlaps with, the receptor complexes of HTLV-1 and HTLV-2.
|
J Virol
|
2009
|
0.81
|
|
25
|
Alterations in mast cell function and survival following in vitro infection with human immunodeficiency viruses-1 through CXCR4.
|
Cell Immunol
|
2004
|
0.81
|
|
26
|
Chemokine receptor-5 (CCR5) is a receptor for the HIV entry inhibitor peptide T (DAPTA).
|
Antiviral Res
|
2005
|
0.81
|
|
27
|
Update on D-ala-peptide T-amide (DAPTA): a viral entry inhibitor that blocks CCR5 chemokine receptors.
|
Curr HIV Res
|
2003
|
0.78
|
|
28
|
Tuberous sclerosis complex 2 gene product interacts with human SMAD proteins. A molecular link of two tumor suppressor pathways.
|
J Biol Chem
|
2004
|
0.77
|
|
29
|
Differential inhibitory effects of cyanovirin-N, griffithsin, and scytovirin on entry mediated by envelopes of gammaretroviruses and deltaretroviruses.
|
J Virol
|
2013
|
0.77
|
|
30
|
Antiviral and immunological benefits in HIV patients receiving intranasal peptide T (DAPTA).
|
Peptides
|
2003
|
0.76
|
|
31
|
Functional and morphologic characterization of human T cells continuously grown in vitro. J. Immunol. 1977. 119: 131-138.
|
J Immunol
|
2007
|
0.75
|